T +1 212 819 8317
So Yeon Choe is an associate in the Intellectual Property Practice Group. Her practice primarily focuses on patent litigation in the pharmaceutical industry.
So Yeon also supports the firm's IP transactional practice in matters related to intellectual property rights and the evaluation of intellectual property portfolios.
Represented UCB and Pfizer in Hatch-Waxman litigation against generic defendants for infringement of five patents covering Toviaz® in the U.S. District Court for the District of Delaware.
Represented Saudi Arabian Oil Company and its affiliates (SAOC) in the separation and distribution of the assets and liabilities of Motiva Enterprises LLC, the US refining joint venture operated by SAOC and Royal Dutch Shell PLC, including in relation to intellectual property and technology licenses and other IP aspects.
Rare Heterozygous Point Mutations in Contactin-Associated Protein-Like 2 (CNTNAP2), or in Other Contactin-Associated Proteins or Contactins, 11 PLOS Genetics 1 , 2015, (co-author)
Misdiagnosing the Impact of Neuroimages in the Courtroom, 61 UCLA L. Rev. 1502, 2014